{"title":"Macrophage Inflammatory Proteins (MIP)","description":null,"products":[{"product_id":"mi-260","title":"Macrophage Inflammatory Protein-2 (MIP-2), Mouse Recombinant","description":"\u003cp\u003eMouse recombinant MIP-2 is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 7.8 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant murine MIP-2 is determined by a localized inflammatory response when injected into the footpads of mice (Wolpe, S.D. et al, Exp. Med. 167, 570 (1987)).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e 0.05 M Ammonium Acetate. Concentration: 1.0 mg protein\/ml.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Nathan, C.F. (1987)J. Clin. Invest. 79:319\u003cbr\u003e2. Wolpe S.D. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:612\u003cbr\u003e3. Tekamp-Olson. P. et al. (1990) J. Exp. Med. 172:911\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use\"\u003e\n\u003ch3 id=\"ab-published-use-mi-260\"\u003ePublished product use\u003c\/h3\u003e\n\u003cp\u003eA peer-reviewed study reported use of murine MIP-2 purchased from Austral Biologicals:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eExperimental chemokine reagent:\u003c\/strong\u003e Murine MIP-2 from Austral Biologicals was used as a reagent in a study of chemokine regulation during collagen-induced arthritis. \u003ca href=\"https:\/\/doi.org\/10.1172\/jci117993\" rel=\"noopener\" target=\"_blank\"\u003eKasama et al., Journal of Clinical Investigation (1995)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-260_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518881755438,"sku":"MI-260-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518881788206,"sku":"MI-260-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-260-10ug.png?v=1788008309"},{"product_id":"mi-270","title":"Mouse recombinant MIP-1 alpha","description":"\u003cp\u003eMouse recombinant MIP-1 alpha is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 7 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant murine MIP-1 alpha is determined by a localized inflammatory response when injected into the footpads of mice (Wolpe, S.D. et al, Exp. Med. 167, 570 (1987)).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e In water at 1 mg\/mL.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1. Wolpe, S.D. et al. (1988) J. Exp. Med. 167:570\u003cbr\u003e2. Graham, G.J. et al. (1994) J. Biol. Chem. 269:4974\u003cbr\u003e3. Dexter, T.M. and White, H. (1990) Nature 344:380\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-270_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518881820974,"sku":"MI-270-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518881853742,"sku":"MI-270-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-270-10ug.png?v=1788008292"},{"product_id":"mi-290","title":"Human recombinant MIP-1 alpha","description":"\u003cp\u003eMacrophage Inflammatory Protein-1( (MIP-1 alpha) is part of the CC subfamily of the chemokine superfamily of chemoattractant cytokines. MIP-1 alpha affects the inflammatory response of blood monocytes, tissue macrophages, and T cells. MIP-1 alpha also enhances the formation of granulocyte-macrophage colonies stimulated by GM-CSF or M-CSF. Human MIP-1 alpha is composed of 69 amino acid residues with not possible N-linked glycosylation sites, and several possible O-linked sites. Human MIP-1 alpha is 60% homologous with human MIP-1 beta, 75% homologous with murine MIP-1 alpha, and has been shown to be active on murine cells. Human recombinant MIP-1 alpha is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 8 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant human MIP-1 alpha is determined by its use as a cofactor for CSF-dependent myelopoiesis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e In water at a concentration of 1.0 mg protein\/ml\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1Nathan, C.F. (1987)J. Clin. Invest. 79:319\u003cbr\u003e2. Wolpe S.D. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:612\u003cbr\u003e3. Tekamp-Olson. P. et al. (1990) J. Exp. Med. 172:911\u003cbr\u003e2. Dunlop, et al (1992) Blood 79: 2221\u003cbr\u003e3. Suzuki, K. et al. (1989) J. Exp. Med. 169:1895\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-290_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518881886510,"sku":"MI-290-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518881919278,"sku":"MI-290-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-290-10ug.png?v=1788008266"},{"product_id":"mi-300","title":"Human recombinant MIP-1 beta","description":"\u003cp\u003eMacrophage Inflammatory Protein MIP-1 beta is part of the CC subfamily of the chemokine superfamily of chemoattractant cytokines. MIP-1 beta affects the inflammatory response of blood monocytes, tissue macrophages, and T cells. MIP-1 beta also enhances the formation of granulocyte-macrophage colonies stimulated by GM-CSF or M-CSF. Human MIP-1 beta is composed of 69 amino acid residues with one possible N-linked glycosylation sites, and several possible O-linked sites. Human MIP-1 beta is 60% homologous with human MIP-1 beta. Human recombinant MIP-1 beta is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 8 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant human MIP-1 alpha is determined by its use as a cofactor for CSF-dependent myelopoiesis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e In water at a concentration of 1.0 mg protein\/ml\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1. Nathan, C.F. (1987)J. Clin. Invest. 79:319\u003cbr\u003e2. Tekamp-Olson. P. et al. (1990) J. Exp. Med. 172:911\u003cbr\u003e3. Wolpe S.D. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:612\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-300_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518881984814,"sku":"MI-300-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518882017582,"sku":"MI-300-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-300-10ug.png?v=1788008279"},{"product_id":"mi-310","title":"Human recombinant MIP-2 alpha","description":"\u003cp\u003eHuman recombinant MIP-2 alpha is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant human MIP-2 alpha is determined by its use as a cofactor for CSF-dependent myelopoiesis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e In 20 mM HEPES\/0.1 M NaCl (ph7.3) at a concentration of 1.0 mg protein\/\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1. Nathan, C.F. (1987)J. Clin. Invest. 79:319\u003cbr\u003e2. Tekamp-Olson. P. et al. (1990) J. Exp. Med. 172:911\u003cbr\u003e3. Wolpe S.D. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:612\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-310_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518882083118,"sku":"MI-310-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518882115886,"sku":"MI-310-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-310-10ug.png?v=1788008277"},{"product_id":"mi-320","title":"Human recombinant MIP-2 beta","description":"\u003cp\u003eHuman recombinant MIP-2 beta is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant human MIP-2 beta is determined by its use as a cofactor for CSF-dependent myelopoiesis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e In 0.1M ammonium acetate at a concentration of 0.50 mg protein\/ml\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1. Nathan, C.F. (1987)J. Clin. Invest. 79:319\u003cbr\u003e2. Tekamp-Olson. P. et al. (1990) J. Exp. Med. 172:911\u003cbr\u003e3. Wolpe S.D. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:612\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-320_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518882148654,"sku":"MI-320-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518882181422,"sku":"MI-320-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-320-10ug.png?v=1788008295"}],"url":"https:\/\/www.australbiologicals.com\/collections\/macrophage-inflammatory-proteins-mip.oembed","provider":"Austral Biologicals","version":"1.0","type":"link"}